Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system

Neuroscience

Volumn 104, Issue 4, 2001, Pages 923-926

  Braida, D ^a   Pozzi, M ^a   Cavallini, R ^a   Sala, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Heroin; Naloxone; Rat; Reward; SR 141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALCOHOL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CREMOPHOR; DIAMORPHINE; DRONABINOL; DRUG VEHICLE; ETONITAZENE; KETAMINE; NALOXONAZINE; NALOXONE; NICOTINE; OPIATE RECEPTOR; PHENCYCLIDINE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BRAIN; CONDITIONING (PSYCHOLOGY); CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEROIN; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REWARD;

EID: 0035800002     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00210-X     Document Type: Article

References (33)

1. Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: Interaction with the opioid system
2. 1) receptors in the establishment of place conditioning in rats
3. Cannabinoid receptors and reward in the rat: A conditioned place preference study
4. 9-Tetrahydrocannabinol produces naloxone-blockade enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious freely moving rats as measured by intracerebral microdialysis
5. Opioid and cannabinoid receptor inhibition of adenyl cyclase in brain
6. 1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats
7. Pharmacologic characterization of nicotine-induced conditioned place preference
8. Cannabinoid interaction with brain reward systems - The neurobiological basis of cannabinoids abuse
9. Facilitation of brain stimulation reward by delta-9-tetrahydrocannabinol
10. Cannabinoid transmission and reward-related events
11. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
12. 9-tetrahydrocannabinol
13. Synergistic effect of opioid and cannabinoid antagonists on food intake
14. 9-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward
15. 9-Tetrahydrocannabinol, but not the endogenous ligand anadamide, produces place avoidance
16. Pharmacological and biochemical interactions between opioids and cannabinoids
17. Self-administration of the cannabinoid agonist WIN 55,212-2 in drug-naive mice
18. Aversive effects of the synthetic cannabinoid CP 55,940 in rats
19. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats
20. Biochemical and pharmacological characterisation of SR 141716A, the first potent and selective brain cannabinoid receptor antagonist
21. Dose-dependent conditioned place preference produced by etonitazene and morphine
22. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization
23. Endogenous cannabinoids as an aversive or counter rewarding system in the rat
24. 9-tetrahydrocannabinol and Kappa opioid in mice
25. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
26. Cannabinoids. I. Behavioral effects
27. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
28. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1-opioid receptor mechanism
29. 9-tetrahydrocannabinol in mice
30. 1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple the other receptors
31. Modulation of rat brain opioid receptors by cannabinoids
32. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine
33. Antinociceptive activity of intrathecally administered cannabinoid alone and in combination with morphine, in mice